Sai Life Sciences Ltd share price was up by 0.61% ... this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and ...

The Competition Commission of India (CCI) has cleared the proposed amalgamation of nine entities with pharmaceutical firm Sequent Scientific Ltd ... Life Sciences are wholly-owned subsidiaries of ...

Combined EBITDA Growth (Viyash and Sequent): 66% for Q3 FY25. Combined Net Debt to EBITDA Ratio: 1.2%, down from 1.4% in the previous quarter. Sequent Scientific Ltd (BOM:512529) reported its ...

Please try again later. DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE ...

The Competition Commission on Tuesday cleared the proposed amalgamation of nine entities with pharmaceutical firm Sequent Scientific Ltd ... Life Sciences are wholly-owned subsidiaries of Viyash ...

The Competition Commission on Tuesday cleared the proposed amalgamation of nine entities with pharmaceutical firm Sequent Scientific Ltd (SSL ... and Vandana Life Sciences are wholly-owned ...

Meanwhile, this would be Carlyle Group’s second platform in India after it set up one in the generic pharmaceuticals segment after partnering Viyash Life Sciences in 2021. Through the platform ...

The Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing ... and Vandana Life Sciences are wholly-owned subsidiaries of Viyash ...

the Company signed a 50:50 joint venture with one of Indias top biotech companies Bharat Serums and Vaccines Ltd (BSV) and formed Zydus BSV Pharma Pvt Ltd to develop, manufacture and market non ...